Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China
· Delayed Price · Currency is CNY 19.59
+0.02 (0.10%)
May 13, 2025, 3:04 PM CST
SHE:300122 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 255.59 | 2,018 | 8,070 | 7,539 | 10,209 | 3,301 | Upgrade
|
| Depreciation & Amortization | 385.01 | 385.01 | 323.71 | 314.94 | 375.85 | 120.93 | Upgrade
|
| Other Amortization | 19.75 | 19.75 | 14.68 | 15.89 | 13.01 | 10.5 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.05 | -0.05 | -41.37 | -0.01 | -0.04 | -0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.36 | 0.36 | 0.13 | 0.09 | 1.68 | 0.55 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 20.03 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 609.27 | 609.27 | 352.59 | 420.87 | 190.74 | 82.93 | Upgrade
|
| Other Operating Activities | 6,528 | 187.57 | 394.49 | 166.06 | 134.48 | 183.92 | Upgrade
|
| Change in Accounts Receivable | 10,173 | 10,173 | -6,756 | -8,056 | -6,546 | -2,249 | Upgrade
|
| Change in Inventory | -13,254 | -13,254 | -1,313 | -765.61 | -3,982 | -974.81 | Upgrade
|
| Change in Accounts Payable | -4,180 | -4,180 | 8,338 | 2,413 | 8,064 | 3,065 | Upgrade
|
| Operating Cash Flow | 163.84 | -4,414 | 8,996 | 1,989 | 8,508 | 3,497 | Upgrade
|
| Operating Cash Flow Growth | -97.16% | - | 352.30% | -76.62% | 143.30% | 155.79% | Upgrade
|
| Capital Expenditures | -844.72 | -930.34 | -1,134 | -1,453 | -1,932 | -826.98 | Upgrade
|
| Sale of Property, Plant & Equipment | 11.1 | 4.76 | 168.07 | 0.65 | 0.32 | 0.1 | Upgrade
|
| Investment in Securities | 4 | - | -10.5 | -45.5 | -69 | -70 | Upgrade
|
| Other Investing Activities | 1.57 | - | - | - | -18.55 | - | Upgrade
|
| Investing Cash Flow | -828.05 | -925.58 | -976.6 | -1,498 | -2,019 | -896.88 | Upgrade
|
| Short-Term Debt Issued | - | 1.16 | 5.54 | 39.08 | 94.63 | 411.63 | Upgrade
|
| Long-Term Debt Issued | - | 14,738 | 6,342 | 5,477 | 2,569 | 6,653 | Upgrade
|
| Total Debt Issued | 16,586 | 14,739 | 6,348 | 5,517 | 2,663 | 7,065 | Upgrade
|
| Short-Term Debt Repaid | - | -1.55 | -0.39 | -18.64 | -75.01 | -216.26 | Upgrade
|
| Long-Term Debt Repaid | - | -10,199 | -9,739 | -6,643 | -5,312 | -8,032 | Upgrade
|
| Total Debt Repaid | -13,246 | -10,200 | -9,739 | -6,661 | -5,387 | -8,249 | Upgrade
|
| Net Debt Issued (Repaid) | 3,341 | 4,539 | -3,391 | -1,145 | -2,723 | -1,184 | Upgrade
|
| Repurchase of Common Stock | -300.03 | -300.03 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -2,567 | -2,528 | -889.29 | -1,015 | -861.96 | -928.7 | Upgrade
|
| Other Financing Activities | 286.09 | -13.52 | -13.08 | -12.82 | -4.76 | -0.72 | Upgrade
|
| Financing Cash Flow | 759.34 | 1,698 | -4,294 | -2,173 | -3,590 | -2,114 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.97 | 1.25 | -2.3 | 17.56 | -9.66 | -4.93 | Upgrade
|
| Net Cash Flow | 96.1 | -3,640 | 3,724 | -1,664 | 2,889 | 481.29 | Upgrade
|
| Free Cash Flow | -680.87 | -5,344 | 7,862 | 535.93 | 6,575 | 2,670 | Upgrade
|
| Free Cash Flow Growth | - | - | 1367.02% | -91.85% | 146.30% | 236.21% | Upgrade
|
| Free Cash Flow Margin | -3.99% | -20.50% | 14.86% | 1.40% | 21.45% | 17.57% | Upgrade
|
| Free Cash Flow Per Share | -0.28 | -2.23 | 3.28 | 0.22 | 2.74 | 1.11 | Upgrade
|
| Cash Income Tax Paid | 1,356 | 2,070 | 3,310 | 3,274 | 1,955 | 875.44 | Upgrade
|
| Levered Free Cash Flow | -7,324 | -10,534 | 1,494 | -3,931 | 2,887 | -96.68 | Upgrade
|
| Unlevered Free Cash Flow | -7,204 | -10,442 | 1,545 | -3,898 | 2,922 | -17.22 | Upgrade
|
| Change in Net Working Capital | 6,981 | 11,378 | 3,413 | 8,212 | 2,987 | 1,829 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.